简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-08-24 13:17 Vifor Pharma and Cara Therapeutics announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients
2021-08-23 09:26 ZOLL and Wallaby Medical Announce Agreement to Distribute Temperature Management Products in China
2021-08-18 16:15 SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline
2021-08-18 15:00 Probiotics for Corals Boost Resilience, Help Prevent Mortality
2021-08-17 08:53 Philip Morris International Enters Tender Period with Vectura Shareholders Following Unanimous Recommendation by Vectura Board
2021-08-13 09:24 Rockley Photonics Announces Successful Closing of Business Combination with SC Health Corp.
2021-08-12 17:37 U.S. Leaders Sign Letter to President Biden to Lead G-7 Effort to Vaccinate Majority of the World’s Population by Year-End
2021-08-12 17:35 SpeeDx Receives Clearance for COVID-19 Diagnostic Test
2021-08-10 18:48 Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics
2021-08-10 11:15 SETi’s Violeds Technology Solution to Support Delta Variant Spreading Prevention
2021-08-09 22:21 Philip Morris International Acquires Inhaled Drug Specialist OtiTopic; Growing Pipeline of “Beyond Nicotine” Inhaled Therapeutic Products
2021-08-06 10:11 Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
2021-08-06 09:07 Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal™ Dx Lung and Colon Cancer Assay
2021-08-05 20:00 Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal™ Dx Lung and Colon Cancer Assay
2021-08-05 13:22 Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1
2021-08-05 09:28 ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients
2021-08-03 16:16 First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
2021-08-03 14:03 Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
2021-08-03 11:32 Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
2021-08-03 11:25 Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress

Business Wire Weibo

Press Releases

Latest Releases